Back to News
Market Impact: 0.2
Needham Initiates Coverage of Clover Health Investments at Buy
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
Needham initiated coverage of Clover Health Investments on October 28, 2026, with a Buy recommendation. The report provides a positive analyst signal, but the article gives no price target, financial estimates, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
CLOV0.55
More News
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Daiichi Sankyo’s first-half profit rises on cancer drug growth; shares up
- Intel plunges on a major guidance miss. What went wrong — and how to proceed
- FedEx Freight delivers a much-needed quarterly beat. Where we stand on shares now
- We're cutting our Amazon price target after a tough quarter. But it isn't all bad
- We're raising our price target on Eli Lilly as the obesity-drug boom rolls on